139 related articles for article (PubMed ID: 35593713)
1. Structure-Based Design of High-Affinity and Selective Peptidomimetic Hepsin Inhibitors.
Knaff PM; Müller P; Kersten C; Wettstein L; Münch J; Landfester K; Mailänder V
Biomacromolecules; 2022 Jun; 23(6):2236-2242. PubMed ID: 35593713
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology.
Damalanka VC; Han Z; Karmakar P; O'Donoghue AJ; La Greca F; Kim T; Pant SM; Helander J; Klefström J; Craik CS; Janetka JW
J Med Chem; 2019 Jan; 62(2):480-490. PubMed ID: 30571119
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship studies of dipeptide-based hepsin inhibitors with Arg bioisosteres.
Kwon H; Ha H; Jeon H; Jang J; Son SH; Lee K; Park SK; Byun Y
Bioorg Chem; 2021 Feb; 107():104521. PubMed ID: 33334587
[TBL] [Abstract][Full Text] [Related]
5. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Hepsin-Targeted Inhibitors.
Kwon H; Han J; Lee KY; Son SH; Byun Y
Curr Med Chem; 2017; 24(21):2294-2311. PubMed ID: 28245763
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial assembly, traceless generation and in situ evaluation of inhibitors for therapeutically relevant serine proteases.
Vu LP; Zyulina M; Hingst A; Schnakenburg G; Gütschow M
Bioorg Chem; 2022 Apr; 121():105676. PubMed ID: 35202850
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of dye-conjugated hepsin inhibitors.
Kim K; Kwon H; Choi D; Lim T; Minn I; Son SH; Byun Y
Bioorg Chem; 2019 Aug; 89():102990. PubMed ID: 31136899
[TBL] [Abstract][Full Text] [Related]
9. α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
Han Z; Harris PK; Karmakar P; Kim T; Owusu BY; Wildman SA; Klampfer L; Janetka JW
ChemMedChem; 2016 Mar; 11(6):585-99. PubMed ID: 26889658
[TBL] [Abstract][Full Text] [Related]
10. Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres.
Müller P; Zimmer C; Frey A; Holzmann G; Weldert AC; Schirmeister T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338655
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in serine protease inhibitors as anticoagulant agents.
Prezelj A; Anderluh PS; Peternel L; Urleb U
Curr Pharm Des; 2007; 13(3):287-312. PubMed ID: 17313362
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-Based Macrocyclic Inhibitors of Serine Proteases.
Damalanka VC; Banas V; De Bona P; Kashipathy MM; Battaile K; Lovell S; Janetka JW
J Med Chem; 2024 Mar; 67(6):4833-4854. PubMed ID: 38477709
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inhibitors of serine proteases with high selectivity through optimization of S' subsite binding.
Li Y; Dou D; He G; Lushington GH; Groutas WC
Bioorg Med Chem; 2009 May; 17(10):3536-42. PubMed ID: 19394830
[TBL] [Abstract][Full Text] [Related]
14. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease.
Frecer V; Miertus S
J Comput Aided Mol Des; 2010 Mar; 24(3):195-212. PubMed ID: 20306283
[TBL] [Abstract][Full Text] [Related]
15. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets.
Katz BA; Sprengeler PA; Luong C; Verner E; Elrod K; Kirtley M; Janc J; Spencer JR; Breitenbucher JG; Hui H; McGee D; Allen D; Martelli A; Mackman RL
Chem Biol; 2001 Nov; 8(11):1107-21. PubMed ID: 11731301
[TBL] [Abstract][Full Text] [Related]
16. Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin.
Damalanka VC; Wildman SA; Janetka JW
Medchemcomm; 2019 Sep; 10(9):1646-1655. PubMed ID: 31803403
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel, potent, and specific family of factor Xa inhibitors via combinatorial chemistry.
Ostrem JA; al-Obeidi F; Safar P; Safarova A; Stringer SK; Patek M; Cross MT; Spoonamore J; LoCascio JC; Kasireddy P; Thorpe DS; Sepetov N; Lebl M; Wildgoose P; Strop P
Biochemistry; 1998 Jan; 37(4):1053-9. PubMed ID: 9454596
[TBL] [Abstract][Full Text] [Related]
18. Analysis of subpocket selectivity and identification of potent selective inhibitors for matriptase and matriptase-2.
Duchêne D; Colombo E; Désilets A; Boudreault PL; Leduc R; Marsault E; Najmanovich R
J Med Chem; 2014 Dec; 57(23):10198-204. PubMed ID: 25387268
[TBL] [Abstract][Full Text] [Related]
19. Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: a P1-P4 SAR study.
Ang MJ; Yong GH; Poulsen A; Then SW; Li Z; Joy J; Hill J; Chia CS
Eur J Med Chem; 2013 Oct; 68():72-80. PubMed ID: 23974013
[TBL] [Abstract][Full Text] [Related]
20. Coumarin and isocoumarin as serine protease inhibitors.
Pochet L; Frédérick R; Masereel B
Curr Pharm Des; 2004; 10(30):3781-96. PubMed ID: 15579071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]